Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Korea United PharmXKRX:033270 -1.38%91 FCF Yield % is 15.10 as of Aug. 22, 2026, which is 173% above its 10-year median of 5.54. GuruFocus rates XKRX:033270 with a GF Score™ of 91/100 and a GF Value™ of ₩20,351.55 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,002 Drug Manufacturers companies, Korea United Pharm ranks better than 87.52% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Korea United Pharm's FCF Yield % or its related term are showing as below:
XKRX:033270'
s FCF Yield % Range Over the Past 10 Years
Min: -0.28 Med: 5.54 Max: 15.1
Current: 15.1
During the past 13 years, the highest FCF Yield % of Korea United Pharm was 15.10%. The lowest was -0.28%. And the median was 5.54%.
XKRX:033270's FCF Yield % is ranked better than 87.52% of 1002
companies
in the Drug Manufacturers industry
Industry Median: 0.57
vs XKRX:033270: 15.10
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Korea United Pharm FCF Yield % Related Terms
Korea United Pharm FCF Yield % Historical Data
* Premium members only.
The historical data trend for Korea United Pharm's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Korea United Pharm's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Korea United Pharm FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Korea United Pharm's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Korea United Pharm's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Korea United Pharm (XKRX:033270) has a FCF Yield % of 15.10 as of Aug. 22, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Korea United Pharm and its competitors. This is 173% above median its historical median of 5.54. According to the industry distribution chart, Korea United Pharm ranks #125 out of 1002 companies in the Drug Manufacturers industry, placing it in the top 12.5%.
Is Korea United Pharm's FCF Yield % too high?
Korea United Pharm's current FCF Yield % of 15.10 is 173% above median its 10-year median of 5.54. The Drug Manufacturers industry median FCF Yield % is 0.57. Korea United Pharm's value of 15.10 is 2549.1% above this industry median. Based on the distribution chart, Korea United Pharm ranks #125 out of 1002 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Korea United Pharm has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Korea United Pharm's FCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Korea United Pharm ranks #125 out of 1002 companies for FCF Yield %. This places Korea United Pharm in the top 13% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 0.57. Korea United Pharm's value of 15.10 is 2549.1% above this benchmark. While the company's 10-year median is 5.54 vs. the industry median of 0.57, Korea United Pharm has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.57, based on 1,002 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Korea United Pharm's current FCF Yield % of 15.10 is 2549.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Korea United Pharm and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Korea United Pharm's current FCF Yield % is 15.10, which is 173% above median its own 10-year median of 5.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Korea United Pharm stock overvalued right now?
Based on GuruFocus' analysis, Korea United Pharm (XKRX:033270) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩20,351.55, compared to a current price of ₩17,910.00 — trading 12% below its estimated fair value. The current FCF Yield % is 15.10, which is 173% above median its 10-year median of 5.54 and 2549.1% above the Drug Manufacturers industry median of 0.57. Korea United Pharm's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Korea United Pharm (XKRX:033270), the current FCF Yield % is 15.10 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Korea United Pharm (XKRX:033270) Overvalued in 2026?
Based on GuruFocus' analysis, Korea United Pharm stock appears to be undervalued.
The current stock price of ₩17,910.00 is trading 12% below its estimated GF Value™ of ₩20,351.55.
GuruFocus considers Korea United Pharm to be Modestly Undervalued.
Key valuation signals for XKRX:033270:
FCF Yield %: 15.10 (173% above median its 10-year median of 5.54)
GF Value™: ₩20,351.55 vs. price of ₩17,910.00 (12% below fair value)
Industry Position: 2549.1% above the Drug Manufacturers median (#125 of 1002)
No single metric tells the full story. See the XKRX:033270 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Korea United Pharm Inc is a South Korea based company engages in the manufacture and distribution of pharmaceuticals and healthcare products. It offers incrementally modified drug, anti-cancer, prescription, and OTC products.
91GF Score
Get the complete analysis for XKRX:033270
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:033270 has been successfully added to your 
